Preprocedural Troponin T Levels Predict the Improvement in the Left Ventricular Ejection Fraction After Catheter Ablation of Atrial Fibrillation/Flutter.
Aged
Atrial Fibrillation
/ diagnosis
Atrial Flutter
/ diagnosis
Biomarkers
/ blood
Catheter Ablation
/ adverse effects
Female
Humans
Male
Middle Aged
Recovery of Function
Retrospective Studies
Risk Assessment
Risk Factors
Stroke Volume
Systole
Time Factors
Treatment Outcome
Troponin T
/ blood
Ventricular Dysfunction, Left
/ blood
Ventricular Function, Left
arrhythmia‐induced cardiomyopathy
atrial fibrillation
catheter ablation
left ventricular dysfunction
troponin T
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
07 04 2020
07 04 2020
Historique:
entrez:
24
3
2020
pubmed:
24
3
2020
medline:
9
3
2021
Statut:
ppublish
Résumé
Background Left ventricular (LV) systolic dysfunction is reversible in some patients once the arrhythmia is controlled. However, identifying this arrhythmia-induced cardiomyopathy among patients with LV systolic dysfunction is challenging. We explored the factors predicting the reversibility of the LV ejection fraction (LVEF) after catheter ablation of atrial fibrillation and/or atrial flutter in patients with LV systolic dysfunction. Methods and Results Forty patients with a reduced LVEF (LVEF <50%; 66.2±10.7 years; 32 men) who underwent atrial fibrillation/atrial flutter ablation were included. Transthoracic echocardiography was performed before and during the early (<4 days) and late phases (>3 months) after the ablation. Responders were defined as having a normalized LVEF (≥50%) during the late phase after the ablation. The LVEF improved from 39.8±8.8 to 50.9±10.9% at 1.2±0.6 days after the procedure, and to 56.2±12.2% at 9.6±8.0 months after the procedure (both for
Identifiants
pubmed: 32200728
doi: 10.1161/JAHA.119.015126
pmc: PMC7428643
doi:
Substances chimiques
Biomarkers
0
Troponin T
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e015126Références
J Am Coll Cardiol. 2012 Nov 20;60(21):2194-204
pubmed: 23103045
J Am Coll Cardiol. 2013 Nov 19;62(21):1990-1997
pubmed: 23850917
Cardiol J. 2014;21(5):516-23
pubmed: 24293166
Eur Heart J. 2016 Aug;37(31):2478-87
pubmed: 26984861
J Am Coll Cardiol. 2017 Oct 17;70(16):1949-1961
pubmed: 28855115
J Am Coll Cardiol. 2019 May 14;73(18):2328-2344
pubmed: 31072578
J Arrhythm. 2017 Oct;33(5):369-409
pubmed: 29021841
J Atr Fibrillation. 2013 Jun 30;6(1):877
pubmed: 28496861
Circulation. 2001 Jan 23;103(3):369-74
pubmed: 11157687
Circulation. 2011 Jun 21;123(24):2811-8
pubmed: 21632491
J Am Coll Cardiol. 2013 May 7;61(18):1894-903
pubmed: 23500267
Eur Heart J. 2008 Sep;29(18):2252-8
pubmed: 18606612
J Am Heart Assoc. 2020 Apr 7;9(7):e015126
pubmed: 32200728
Heart Vessels. 2020 Feb;35(2):239-245
pubmed: 31346694
Circ Arrhythm Electrophysiol. 2014 Feb;7(1):31-8
pubmed: 24382410
Circ J. 2013;77(7):1695-704
pubmed: 23535197
Cardiovasc Res. 2017 Dec 1;113(14):1708-1718
pubmed: 29016754
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
J Am Coll Cardiol. 2010 Sep 28;56(14):1071-8
pubmed: 20863950
Circulation. 2003 Aug 19;108(7):833-8
pubmed: 12912820
JAMA Cardiol. 2016 Aug 1;1(5):510-8
pubmed: 27434402
J Cardiovasc Electrophysiol. 2019 Sep;30(9):1475-1482
pubmed: 31192482
Int Heart J. 2015 May 13;56(3):309-13
pubmed: 25912901
J Cardiol. 2018 Sep;72(3):240-246
pubmed: 29609877
Circulation. 2016 Apr 26;133(17):1637-44
pubmed: 27029350
N Engl J Med. 2018 Feb 01;378(5):417-427
pubmed: 29385358